Victoria Villaflor, MD, Clinical Professor, Director Head and Neck Oncology, City of Hope

As ongoing research continues to unlock the mechanisms of non–small cell lung cancer, it’s becoming increasingly clear that healthcare providers need to start rethinking how treatment is approached—especially for Stage 3 disease.